KOD
Kodiak Sciences Inc.
KOD
Kodiak Sciences Inc.
For small-cap biotech investors, a single date on the calendar can matter more than a quarter's worth of earnings reports. These companies often burn cash for years without product revenue, betting ev
Phase 3 ALTO trial designed to demonstrate superiority of KSI-501 versus aflibercept in patients with diabetic macular edema PALO ALTO, Calif., Aug. 10, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasd
Kodal Minerals PLC (AIM:KOD), the West African lithium producer, has received an initial $13 million repayment from the operator of its Bougouni project in Mali, as strong spodumene prices continue to